We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $97M
1-Year Est. Return 57.2%
This Fund
S&P 500
This Quarter Est. Return
+10.39%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
AUM
$38.3M
AUM Growth
+$3.91M
Cap. Flow
+$5.04M
Cap. Flow %
13.16%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ABGI
ABG Acquisition Corp. I
ABGI
+$5.04M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 87.06%
2 Financials 12.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVIR icon
1
Atea Pharmaceuticals
AVIR
$385M
$18.5M 48.35%
300,000
LUNG icon
2
Pulmonx
LUNG
$51.1M
$13.9M 36.18%
303,030
ABGI
3
DELISTED
ABG Acquisition Corp. I
ABGI
$4.96M 12.94%
+501,300
New +$5.04M
SYRE icon
4
Spyre Therapeutics
SYRE
$8.88B
$887K 2.32%
4,482
CRVO icon
5
CervoMed
CRVO
$25.6M
$82K 0.21%
1,198

Similar funds

Yu Fan's Q1 2021 Portfolio in Review

As of Q1 2021, Yu Fan held 5 positions worth $38.3M, up 11% from $34.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Yu Fan deployed $5.04M of net new capital in Q1 2021, opening 1 new position. Its largest new stake was ABG Acquisition Corp. I: 501,300 shares worth $4.96M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 100% a quarter earlier, followed by Financials.

  • Yu Fan's largest Q1 2021 buy was ABG Acquisition Corp. I: 501,300 shares worth $4.96M.
  • Yu Fan's ten largest holdings make up 100% of its $38.3M portfolio in Q1 2021.
  • Yu Fan opened 1 new position and closed 0 in Q1 2021.
  • Yu Fan's portfolio value rose 11% quarter-over-quarter to $38.3M.

Based on Yu Fan's 13F filing for Q1 2021, filed 17 May 2021.